Navigation Links
Pig wasting syndrome costing farmers millions
Date:3/26/2013

  • First economic models showing impact of post-weaning multi-systemic wasting syndrome (PMWS) on British Pig Industry published

  • Between 8 to 84 per pig lost, depending on severity of PMWS

  • Farm-level intervention could save farmers up to 11,500 per year

Stark new figures show that a common pig virus, present on 99 per cent of pig farms has major economic implications for individual farmers and the pig industry as a whole, costing British farmers as much as 84 per pig (if the pig dies from the syndrome), and during epidemic periods, such as 2008, costing the pig industry 88M per year.

PMWS, a serious syndrome which results in emaciation and death in up to 30 per cent of cases. As part of a BBSRC-led initiative into combating endemic diseases of farmed animals, researchers from the Royal Veterinary College (RVC) have spent the past five years working to understand the factors that lead to farms developing high rates of PMWS and creating models to work out the cost of the disease as well as the potential savings for farmers by tackling the disease in different ways.

Professor Dirk Werling, from RVC, who led the project, explains: "We've known for many years that this is a serious disease in pigs. It is now endemic globally and will haunt the pig industry for years to come; therefore it is crucial that we understand the biological basis of the virus as well as the cost implications. Knowing the financial impact of the illness can help farmers decide how best to improve the welfare and profitability of their herds. These figures are shocking, but are an important step in enabling farmers and the industry as a whole to look at feasible and sustainable intervention strategies."

Dr Pablo Alarcon, Professor Jonathan Rushton and Dr Barbara Wieland, all from RVC, produced a series of mathematical models, factoring in different scenarios such as the size of the pig herds, the proportion affected by PMWS and the severity of the infection. In the most severe cases where the infected pig dies from PMWS, this costs the farmer an estimated 84, with the least severe case - where a pig is carrying the virus but displays no clinical symptoms cost 8.

Models were then created to look at the cost implications of employing different control measures at individual farm level, ranging from vaccination of piglets through to total repopulation of a farm's pig stocks. Their model suggests that on farms with moderate to high rates of PMWS the most cost effective strategy is to vaccinate all piglets and increase biosecurity measures, such as a two day quarantine period for people who had come into contact with other pig herds and treating pigs with PMWS in isolation. Savings from this dual approach were worked out to be between 2,947 to 11,500 per year.

BBSRC Chief Executive Professor Douglas Kell said: "Food security and the sustainability of UK farming are seriously undermined by endemic diseases of farmed animals. This important new research shows the significant economic impact that diseases such as PMWS can cause, and highlights the vital role researchers play in working with farmers and industry to improve food security and animal welfare"


'/>"/>

Contact: Chris Melvin
press.office@bbsrc.ac.uk
44-179-341-4694
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Related biology news :

1. Liver controls wasting in cancer
2. Found a genetic mutation causing mental retardation very similar to Angelman syndrome in Amish
3. NIH awards nearly $2 million to 3 NYC institutions for chronic fatigue syndrome research
4. Researchers id queens, mysterious disease syndrome as key factors in bee colony deaths
5. Study reveals significance of second trimester markers for Downs syndrome
6. UCI study reveals why Down syndrome boosts susceptibility to other conditions
7. Study offers insights into role of muscle weakness in Down syndrome
8. Snack attack: Eating unhealthy snack foods may affect cancer risk in patients with Lynch syndrome
9. Ray of hope for human Usher syndrome patients
10. Lack of nutrients and metabolic syndrome linked to different subtypes of depression
11. Extra chromosome 21 removed from Down syndrome cell line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ... February 23, 2017 , ... ... a published evaluation of multiple immunoassay-based threat detection technologies by researchers from ... PathSensors’ CANARY® biosensor threat detection technology was found to have the best ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The Greater ... a new partnership with Compass Research . GGI's mission is to advance global ... to a child in need in honor of each clinical trial volunteer. The vision ...
(Date:2/23/2017)... DIEGO and SAN FRANCISCO ... a privately-held regenerative medicine company, and Beyond Type 1, ... with type 1 diabetes, today announced a grant from ... a functional cure for type 1 and other insulin-requiring ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , ... Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology spin-out ... research and clinical applications. The terms of the transaction were not disclosed. ...
Breaking Biology Technology: